Pediatric anesthesia & critical care

Decreasing Opioid Usage in Pediatric Cholecystectomy Through Care Standardization: A Quality Improvement Project Using Enhanced Recovery After Surgery Protocols

Paediatr AnaesthPublished Quality improvement study

Authors' conclusion

Standardizing care through enhanced recovery after surgery protocols effectively reduces opioid use in pediatric laparoscopic cholecystectomy without increasing mean postoperative pain scores, postoperative nausea and vomiting, pruritus, or hospital length of stay.

Study context

Population
Pediatric laparoscopic cholecystectomy patients at a 443-bed pediatric academic hospital
Comparison
ERAS protocol vs pre-ERAS perioperative care
Outcome
Opioid use in MME (aim: 25% reduction)
Follow-up
32 months
Methodological detailsModel for Improvement, pre-post comparison, single-centre, 5 months testing and implementing the protocol, then 27 months of full implementation
  • Model for Improvement
  • Pre-post comparison
  • Single-centre
  • 5 months testing and implementing the protocol, then 27 months of full implementation

Main finding

As reported in the abstract

Opioid use (MME)

MME decreased after full ERAS protocol implementation

27%

Further findings

Hospital LOS · balancing measure

Mean

OutcomePre-ERASPost-ERAS
Pain scoresBalancing measure4.69 (95% CI 4.32–5.06)4.10 (95% CI 3.84–4.36)

Safety

PONV incidence

PONV incidence decreased from 18% (95% CI: 11.7-26.7) to 15% (95% CI: 9.3-23.3)

Pruritus incidence

Pruritus incidence declined from 6% (95% CI: 2.8-12.5) to 5% (95% CI: 2.2-11.2)

30-day readmission rate

Unchanged; sole readmission attributed to constipation

Original publication

Decreasing Opioid Usage in Pediatric Cholecystectomy Through Care Standardization: A Quality Improvement Project Using Enhanced Recovery After Surgery Protocols. Paediatr Anaesth. Published 2 April 2025. doi:10.1111/pan.15103

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.